258 related articles for article (PubMed ID: 10666251)
1. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody.
Welsh RM; Markees TG; Woda BA; Daniels KA; Brehm MA; Mordes JP; Greiner DL; Rossini AA
J Virol; 2000 Mar; 74(5):2210-8. PubMed ID: 10666251
[TBL] [Abstract][Full Text] [Related]
2. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
[TBL] [Abstract][Full Text] [Related]
3. Viral infection abrogates CD8(+) T-cell deletion induced by costimulation blockade.
Turgeon NA; Iwakoshi NN; Phillips NE; Meyers WC; Welsh RM; Greiner DL; Mordes JP; Rossini AA
J Surg Res; 2000 Sep; 93(1):63-9. PubMed ID: 10945944
[TBL] [Abstract][Full Text] [Related]
4. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
[TBL] [Abstract][Full Text] [Related]
5. Viral abrogation of stem cell transplantation tolerance causes graft rejection and host death by different mechanisms.
Forman D; Welsh RM; Markees TG; Woda BA; Mordes JP; Rossini AA; Greiner DL
J Immunol; 2002 Jun; 168(12):6047-56. PubMed ID: 12055213
[TBL] [Abstract][Full Text] [Related]
6. Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliteration.
Miller HL; Shah PD; Orens JB; McDyer JF
J Heart Lung Transplant; 2013 Sep; 32(9):914-24. PubMed ID: 23953819
[TBL] [Abstract][Full Text] [Related]
7. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
[TBL] [Abstract][Full Text] [Related]
8. Prolonged survival of neonatal porcine islet xenografts in mice treated with a donor-specific transfusion and anti-CD154 antibody.
Appel MC; Banuelos SJ; Greiner DL; Shultz LD; Mordes JP; Rossini AA
Transplantation; 2004 May; 77(9):1341-9. PubMed ID: 15167588
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of donor-specific transfusion sources: unique failure of bone marrow cells to induce prolonged skin allograft survival with anti-CD154 monoclonal antibody.
Markees TG; Pearson T; Cuthbert A; Pearson AL; Shultz LD; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
Transplantation; 2004 Dec; 78(11):1601-8. PubMed ID: 15591948
[TBL] [Abstract][Full Text] [Related]
10. NOD mice have a generalized defect in their response to transplantation tolerance induction.
Markees TG; Serreze DV; Phillips NE; Sorli CH; Gordon EJ; Shultz LD; Noelle RJ; Woda BA; Greiner DL; Mordes JP; Rossini AA
Diabetes; 1999 May; 48(5):967-74. PubMed ID: 10331399
[TBL] [Abstract][Full Text] [Related]
11. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
Thornley TB; Brehm MA; Markees TG; Shultz LD; Mordes JP; Welsh RM; Rossini AA; Greiner DL
J Immunol; 2006 Feb; 176(3):1561-70. PubMed ID: 16424185
[TBL] [Abstract][Full Text] [Related]
12. Skin allograft maintenance in a new synchimeric model system of tolerance.
Iwakoshi NN; Markees TG; Turgeon N; Thornley T; Cuthbert A; Leif J; Phillips NE; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2001 Dec; 167(11):6623-30. PubMed ID: 11714833
[TBL] [Abstract][Full Text] [Related]
13. Studies investigating pretransplant donor-specific blood transfusion, rapamycin, and the CD154-specific antibody IDEC-131 in a nonhuman primate model of skin allotransplantation.
Xu H; Montgomery SP; Preston EH; Tadaki DK; Hale DA; Harlan DM; Kirk AD
J Immunol; 2003 Mar; 170(5):2776-82. PubMed ID: 12594309
[TBL] [Abstract][Full Text] [Related]
14. Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates.
Elster EA; Xu H; Tadaki DK; Montgomery S; Burkly LC; Berning JD; Baumgartner RE; Cruzata F; Marx R; Harlan DM; Kirk AD
Transplantation; 2001 Nov; 72(9):1473-8. PubMed ID: 11707732
[TBL] [Abstract][Full Text] [Related]
15. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection.
Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A
Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995
[TBL] [Abstract][Full Text] [Related]
16. Rat xenograft survival in mice treated with donor-specific transfusion and anti-CD154 antibody is enhanced by elimination of host CD4+ cells.
Gordon EJ; Woda BA; Shultz LD; Rossini AA; Greiner DL; Mordes JP
Transplantation; 2001 Jan; 71(2):319-27. PubMed ID: 11213080
[TBL] [Abstract][Full Text] [Related]
17. Combined donor specific transfusion and anti-CD154 therapy achieves airway allograft tolerance.
Chalermskulrat W; McKinnon KP; Brickey WJ; Neuringer IP; Park RC; Sterka DG; Long BR; McNeillie P; Noelle RJ; Ting JP; Aris RM
Thorax; 2006 Jan; 61(1):61-7. PubMed ID: 16254057
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.
Markees TG; Phillips NE; Gordon EJ; Noelle RJ; Shultz LD; Mordes JP; Greiner DL; Rossini AA
J Clin Invest; 1998 Jun; 101(11):2446-55. PubMed ID: 9616216
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
Li JM; Gorechlad J; Larsen CP; Waller EK
Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
[TBL] [Abstract][Full Text] [Related]
20. The complement dependent cytotoxicity (CDC) immune effector mechanism contributes to anti-CD154 induced immunosuppression.
Sánchez-Fueyo A; Domenig C; Strom TB; Zheng XX
Transplantation; 2002 Sep; 74(6):898-900. PubMed ID: 12364878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
